Premium
Onycholysis and subungual haemorrhages secondary to systemic chemotherapy (paclitaxel)
Author(s) -
Ghetti E,
Piraccini BM,
Tosti A
Publication year - 2003
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1046/j.1468-3083.2003.00774.x
Subject(s) - onycholysis , medicine , taxane , nail (fastener) , nail disease , dermatology , paclitaxel , paronychia , surgery , nail plate , chemotherapy , cancer , breast cancer , materials science , metallurgy
Paclitaxel is a chemotherapic agent of the taxane family used in treatment of malignant solid tumory. We report here the case of a 40‐year old woman referred to our clinic for nail changes involving all 20 digits and developed after 5 months of paclitaxel intake, due to a breast carcinoma. Clinical examination revealed red‐brown discoloration of the nails associated with hematomas and onycholysis. The nail changes were very painful and the patient complained of discharge of bad‐smelling yellow brown opaque fluid from underneath the nail plate. Hemorrhagic onycholysis and subungual abscesses are a possible side effect of taxane treatment that should be early recognized to prevent serious complications.